[Fareon]
000%
Restoring brain function
through biophysics
[Science]

A noninvasive therapy that can promote brain repair.

Electromagnetic field
Low-intensity radiofrequency
Biology
Lowers inflammation and activates repair signaling
Reach
Passes through the skull to deep brain structures
Setting
At home, under clinical oversight
[Mechanism]

How MMT works: from broad exposure to lasting repair.

A head-worn device delivers a low-intensity field that reaches deep brain structures, engages redox biology, lowers inflammation and turns on repair signaling.

[Whole-brain exposure]
Brain receiving microtesla magnetic field
  1. 01 · Deliver

    Broad brain exposure

    A low-intensity field passes unimpeded through the skull and reaches deep brain structures.

  2. 02 · Engage

    Redox biology

    Preclinical studies show Microtesla Magnetic Therapy (MMT) modulates redox-sensitive signaling and reduces neuronal oxidative stress.

  3. 03 · Reduce

    Less inflammation

    MMT reduces inflammatory cytokines and microglial activation in human cell and rat models.

  4. 04 · Restore

    Repair of brain tissue

    Growth and repair signaling is activated, with evidence of reduced neuronal stress and tissue injury.

[Why MMT is different]

Designed for treatment at home.

Safety
0

Serious adverse events in our first human study1

No systemic exposure, no device-related adverse events, no perceptible sensation (n=30).

Breadth
Whole-brain

Multi-pathway activity across cell types2

Anti-inflammatory and neuroprotective effects in neurons and glia, relevant to many disease states.

Home use
4.8/5

Rated for ease of use and convenience

All 30 participants who completed the study received eight treatments at home.

Repair
Evidence of cellular repair

Strong signals that MMT restores cellular function and promotes durable repair, not temporary symptom management.2

[References]

1. Two adverse events in the active group, both unrelated to treatment (ankle injury; SARS-CoV-2 reinfection). Canori et al., Brain Communications (2026).
2. Whole-brain, multi-pathway mechanism; evidence of cellular repair. Nguyen et al., iScience (2026).

Effect size (Cohen's d) for change from baseline to week 8, active (n=20) vs. sham (n=10). Canori et al., Brain Communications (2026). Markers show conventional thresholds: small 0.2, medium 0.5, large 0.8. P-values, uncorrected: emotional well-being 0.017, working memory 0.026, verbal learning 0.044, processing speed 0.049.
[Clinical · Brain Communications 2026]

MMT studied in a triple-blind, randomized, sham-controlled trial.

In this first-in-human feasibility study, MMT was well tolerated, with between-group improvements in working memory, verbal learning, processing speed and emotional well-being. A companion analysis of ~10,500 plasma proteins points to a shift from inflammation toward repair.

30

Participants
(20 active / 10 sham)

15 min

Per at-home treatment session
(8 sessions over 4 weeks)

0

Serious adverse events

11K

Plasma proteins measured with the SomaScan 11K assay

Proteomics preprint on medRxiv

Findings of feasibility study to be confirmed in larger controlled trials.

[Plasma proteomics · SomaScan 11K]

The clinical response comes with focused protein remodeling, converging on inflammation resolution and repair.

Selective protein remodeling identified

Lower inflammation and injury signals in responders

Higher repair and remodeling biology in responders

“This is the first data I have seen suggesting that restoration of lost function may be possible.”
Dr. David PutrinoDr. David PutrinoDirector of Rehabilitation Innovation, Mount SinaiPrincipal investigator of the MMT pilot study
[Preclinical · iScience 2026]

The biology behind MMT’s effect on inflammation:

Graphical abstract of the iScience study
[Graphical abstract · iScience 2026]

Our peer-reviewed study reports that MMT reduced inflammatory signaling and cytokine release in human immune cells, reduced oxidative stress in neuronal models, and reduced microglial activation and tissue injury in a rat model of neuroinflammation.

Human immune cells
↓ Cytokine release
Neuronal models
↓ Oxidative stress
Rat neuroinflammation model
↓ Microglial activation
Read the paper in iScience
[Publications]

Science in the open.

[Brain Communications · 2026]

Microtesla magnetic therapy for cognitive impairment in long COVID: a randomized pilot study

Canori et al. · Peer-reviewed

[medRxiv · 2026]

Plasma Proteomics Identifies a Microtesla Magnetic Therapy Response Signature in Long COVID

Brady et al. · Preprint, currently under peer review

[iScience · 2026]

Transcranial microtesla magnetic fields suppress neuroinflammation and neuronal oxidative stress burden

Nguyen et al. · Peer-reviewed